-
Organigram Strives For 'High Potency Cannabinoid' With $6M Phylos Investment
Tuesday, November 28, 2023 - 2:42pm | 493OrganiGram Holdings Inc (NASDAQ:OGI), a Canadian cannabis operator producer, has increased its investment in Phylos Bioscience Inc., a U.S.-based cannabis genetics company. Following the achievement of a crucial milestone under their May 2023 loan agreement, Organigram has closed the second tranche...
-
A 'Legend' For 50 Years, This Rare Weed Compound Is Finally Popping Up In California Dispensaries
Wednesday, October 25, 2023 - 11:23am | 479In 1970, University of Oxford researchers unveiled the discovery of tetrahydrocannabivarin (THCV), a unique cannabis compound distinct from the well-known THC and CBD. For decades, its elusive nature conferred it a legendary status, earning denominations like “the sports car of weed” or...
-
'Consumers Expect More From Cannabis Producers': Organigram Unveils THCV Products From Exclusive Genetics
Monday, August 28, 2023 - 12:07pm | 459Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands. The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the...
-
Organigram Invests In Phylos Bioscience To Commercialize THCV And Scale Seed Based Production
Friday, May 26, 2023 - 9:02am | 486Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has reached agreement with Phylos Bioscience Inc., to initiate a wide-ranging technical and commercial relationship in Canada. This innovation relationship is expected to further support Organigram’s cultivation efforts in Canada with patent-...
-
MariMed, Indiva And Other Cannabis Companies Pitch Investors
Tuesday, October 29, 2019 - 5:21pm | 677Six cannabis executives made their pitch to investors last week at the Benzinga Cannabis Capital Conference in Chicago. MariMed Bob Fireman, CEO and president of Marimed Inc (OTC: MRMD), began his presentation by highlighting the industry's responsibility to patients and their medical...